Published in Proc Natl Acad Sci U S A on June 22, 1999
Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol (2001) 8.95
Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest (2002) 3.86
Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest (2003) 3.09
Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest (2003) 3.02
Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab (2010) 2.89
Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab (2008) 2.76
Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev (2008) 2.68
Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev (2008) 2.64
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest (2005) 2.24
PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J Clin Invest (2003) 2.23
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev (2001) 2.18
Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci U S A (2000) 2.17
mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab (2011) 2.11
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle (2011) 2.10
Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest (2006) 2.03
Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions. Nature (2013) 2.02
Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes (2008) 1.97
Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene. Nucleic Acids Res (2000) 1.97
The role of liver-derived insulin-like growth factor-I. Endocr Rev (2009) 1.87
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest (2004) 1.82
Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr Rev (2009) 1.76
Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci U S A (2004) 1.75
Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res (2008) 1.72
Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency. J Clin Invest (2005) 1.70
Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res (2010) 1.69
Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem (2009) 1.69
The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol (2013) 1.68
Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol (2003) 1.62
Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling. J Physiol (2011) 1.59
IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes (2007) 1.56
Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest (2000) 1.54
Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol Rev (2013) 1.50
Emerging therapeutic opportunities for skeletal restoration. Nat Rev Drug Discov (2011) 1.48
Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev (2007) 1.45
Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol (2008) 1.44
Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. Endocr Rev (2010) 1.44
Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol (2011) 1.43
Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology (2003) 1.43
Macrophage and adipocyte IGF1 maintain adipose tissue homeostasis during metabolic stresses. Obesity (Silver Spring) (2015) 1.41
Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation. J Exp Med (2009) 1.39
Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther (2003) 1.38
Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm IGF Res (2009) 1.35
Neurobiological markers of exercise-related brain plasticity in older adults. Brain Behav Immun (2012) 1.31
The hormonal action of IGF1 in postnatal mouse growth. Proc Natl Acad Sci U S A (2008) 1.31
Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest (2002) 1.30
Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev (2004) 1.30
Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol (2000) 1.29
Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. J Bone Miner Res (2009) 1.29
The IGF axis and hepatocarcinogenesis. Mol Pathol (2001) 1.26
Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism. FASEB J (2008) 1.23
Targeting insulin-like growth factor axis in hepatocellular carcinoma. J Hematol Oncol (2011) 1.22
Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. J Clin Invest (2007) 1.22
Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo. Mol Cell Biol (2006) 1.21
Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice. Endocrinology (2009) 1.21
The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival. Oncogene (2009) 1.20
Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. Endocrinology (2007) 1.18
Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice. Physiol Genomics (2007) 1.17
Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression. Mol Cell Biol (2008) 1.17
Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Natl Acad Sci U S A (2000) 1.16
Liver steatosis and increased ChREBP expression in mice carrying a liver specific SIRT1 null mutation under a normal feeding condition. Int J Biol Sci (2010) 1.16
Hormonal regulation of longevity in mammals. Ageing Res Rev (2007) 1.15
Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol (2008) 1.15
IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors. J Cell Biol (2005) 1.14
Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflugers Arch (2008) 1.13
Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice. J Biol Chem (2012) 1.13
Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Transl Med (2012) 1.12
Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit. Growth Horm IGF Res (2007) 1.11
Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1. Mamm Genome (2004) 1.10
Dynamic in vivo binding of STAT5 to growth hormone-regulated genes in intact rat liver. Sex-specific binding at low- but not high-affinity STAT5 sites. Mol Endocrinol (2009) 1.09
Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites. Endocrinology (2008) 1.09
Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling. Cancer Prev Res (Phila) (2013) 1.08
Hormonal control of aging in rodents: the somatotropic axis. Mol Cell Endocrinol (2008) 1.07
Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis. J Clin Invest (2004) 1.06
Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction. Rejuvenation Res (2008) 1.06
Minireview: mechanisms of growth hormone-mediated gene regulation. Mol Endocrinol (2014) 1.04
Spontaneous development of hepatocellular carcinoma with cancer stem cell properties in PR-SET7-deficient livers. EMBO J (2014) 1.03
Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am (2012) 1.02
Diverse roles of growth hormone and insulin-like growth factor-1 in mammalian aging: progress and controversies. J Gerontol A Biol Sci Med Sci (2012) 1.02
Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. Endocrinology (2014) 1.02
Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1 mRNA expression and histone structure in rapid vs. delayed postnatal catch-up growth. Am J Physiol Gastrointest Liver Physiol (2010) 1.02
Studies of Caenorhabditis elegans DAF-2/insulin signaling reveal targets for pharmacological manipulation of lifespan. Aging Cell (2006) 1.02
Zebrafish IGF genes: gene duplication, conservation and divergence, and novel roles in midline and notochord development. PLoS One (2009) 1.02
The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting. Pediatr Nephrol (2005) 1.02
The multi-functional role of insulin-like growth factor binding proteins in bone. Pediatr Nephrol (2004) 1.01
Insulin-like growth factor-I and bone: lessons from mice and men. Pediatr Nephrol (2008) 1.01
Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression. Cancer Res (2008) 1.01
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol (2009) 1.00
Anabolic effects of IGF-1 signaling on the skeleton. Front Endocrinol (Lausanne) (2013) 1.00
Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor. FASEB J (2009) 1.00
E-peptides control bioavailability of IGF-1. PLoS One (2012) 1.00
Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Mol Endocrinol (2010) 0.99
Genomic dissection of the cytokine-controlled STAT5 signaling network in liver. Physiol Genomics (2008) 0.99
Neurodevelopmental effects of insulin-like growth factor signaling. Front Neuroendocrinol (2012) 0.98
Genetic reduction of insulin-like growth factor-1 mimics the anticancer effects of calorie restriction on cyclooxygenase-2-driven pancreatic neoplasia. Cancer Prev Res (Phila) (2011) 0.97
Skeletal aging and the adipocyte program: New insights from an "old" molecule. Cell Cycle (2010) 0.97
A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis. J Endocrinol (2009) 0.97
Association of handgrip strength with chronic diseases and multimorbidity: a cross-sectional study. Age (Dordr) (2012) 0.96
Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function. Nat Commun (2013) 0.96
Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A (1988) 10.90
Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell (1993) 10.36
Role of insulin-like growth factors in embryonic and postnatal growth. Cell (1993) 8.22
Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev (1995) 3.58
Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev (1989) 3.55
Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc Natl Acad Sci U S A (1982) 3.37
IGF-I is required for normal embryonic growth in mice. Genes Dev (1993) 3.17
Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol (1993) 3.15
Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci U S A (1984) 3.13
Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev (1997) 2.63
Quantitative changes in DNA, RNA, and protein during prenatal and postnatal growth in the rat. Dev Biol (1965) 2.52
Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev Biol (1980) 2.11
Growth hormone stimulates longitudinal bone growth directly. Science (1982) 1.83
Site-directed mutagenesis reveals a liver transcription factor essential for the albumin transcriptional enhancer. Proc Natl Acad Sci U S A (1990) 1.77
Growth factors and the regulation of bone remodeling. J Clin Invest (1988) 1.73
Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem (1986) 1.67
Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev (1987) 1.63
Conditional enhancement of liver-specific gene transcription. Proc Natl Acad Sci U S A (1988) 1.61
Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol (1998) 1.52
Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci U S A (1992) 1.48
Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A (1989) 1.44
Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology (1994) 1.28
In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone (1991) 1.19
Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development (1991) 1.14
Differential expression of albumin and alpha-fetoprotein genes in fetal tissues of mouse and rat. Dev Biol (1984) 1.13
Histochemical localization of IGF-I and -II mRNA in the developing rat embryo. Development (1987) 1.08
The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. J Endocrinol (1992) 1.08
Prealbumin gene expression during mouse development studied by in situ hybridization. Cell Differ (1987) 1.05
Tissue and development specific regulation of a complex family of rat insulin-like growth factor I messenger ribonucleic acids. Mol Endocrinol (1988) 0.97
Effects of growth hormone administration and dietary protein intake on insulin-like growth factor I and growth hormone receptor mRNA Expression in porcine liver, skeletal muscle, and adipose tissue. J Anim Sci (1996) 0.96
Effects of insulin-like growth factor-I (IGF-I) infusion and dietary tri-iodothyronine (T3) supplementation on growth, body composition and plasma hormone levels in sex-linked dwarf mutant and normal chickens. J Endocrinol (1992) 0.94
Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue. Endocrinology (1993) 0.94
The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs? J Endocrinol (1990) 0.91
Growth kinetics of mammalian embryos during the stage of differentiation. Naunyn Schmiedebergs Arch Pharmacol (1972) 0.87
A gene map of the human genome. Science (1996) 14.32
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A (1996) 12.92
A physical map of 30,000 human genes. Science (1998) 12.43
Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J (1999) 10.82
Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A (1992) 9.19
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell (1998) 8.10
Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol Cell Biol (1987) 5.84
The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest (2001) 4.93
Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell (1997) 4.20
Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J Biol Chem (1999) 3.95
The somatomedin hypothesis: 2001. Endocr Rev (2001) 3.16
Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest (2000) 3.01
Misleading funnel plot for detection of bias in meta-analysis. J Clin Epidemiol (2000) 2.90
Bacteriophage P1 cre gene and its regulatory region. Evidence for multiple promoters and for regulation by DNA methylation. J Mol Biol (1986) 2.80
Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev (2001) 2.78
Genomic targeting with purified Cre recombinase. Nucleic Acids Res (1993) 2.74
Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci U S A (1992) 2.72
Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proc Natl Acad Sci U S A (1998) 2.71
Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A (1999) 2.62
Citation patterns in the health sciences: implications for serials/monographic fund allocation. Bull Med Libr Assoc (1993) 2.48
Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat Genet (1998) 2.44
Nonmuscle myosin II-B is required for normal development of the mouse heart. Proc Natl Acad Sci U S A (1997) 2.35
Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A (2001) 2.35
K+ current diversity is produced by an extended gene family conserved in Drosophila and mouse. Science (1990) 2.33
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem (1998) 2.24
A positive selection vector for cloning high molecular weight DNA by the bacteriophage P1 system: improved cloning efficacy. Proc Natl Acad Sci U S A (1992) 2.20
An essential 'set' of K+ channels conserved in flies, mice and humans. Trends Neurosci (1992) 2.19
Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med (2002) 2.13
Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Biol Chem (1997) 2.12
Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A (1996) 2.09
Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N Engl J Med (1997) 2.05
The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts. J Biol Chem (1997) 1.98
Genomic organization and deduced amino acid sequence of a putative sodium channel gene in Drosophila. Science (1987) 1.92
Epigenetic self-regulation of developmental excision of an internal eliminated sequence on Paramecium tetraurelia. Genes Dev (1995) 1.91
Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer (1985) 1.87
mShal, a subfamily of A-type K+ channel cloned from mammalian brain. Proc Natl Acad Sci U S A (1991) 1.82
Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol (1998) 1.81
Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol (1997) 1.80
AutoCSA, an algorithm for high throughput DNA sequence variant detection in cancer genomes. Bioinformatics (2007) 1.80
A bacterial mutation blocking P2 phage late gene expression. Proc Natl Acad Sci U S A (1975) 1.79
Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc Natl Acad Sci U S A (1992) 1.78
Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci U S A (2004) 1.75
Self-assembling amphiphilic siderophores from marine bacteria. Science (2000) 1.73
Disruption of the c/ebp alpha gene in adult mouse liver. Mol Cell Biol (1997) 1.72
Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology (1997) 1.68
Photochemical cycling of iron in the surface ocean mediated by microbial iron(III)-binding ligands. Nature (2001) 1.67
Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med (1997) 1.67
Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J Biol Chem (1999) 1.60
Site-directed recombination in the genome of transgenic tobacco. Mol Gen Genet (1990) 1.60
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes (2001) 1.59
Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci U S A (1993) 1.59
Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor. Mol Cell Biol (2001) 1.58
Mutations in the insulin receptor gene. Endocr Rev (1992) 1.55
Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem (2001) 1.54
Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol (1998) 1.52
Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes (1994) 1.52
The role of the insulin-like growth factor system in human cancer. Adv Cancer Res (1996) 1.52
Setting up a quality assurance program in endoscopy. Endoscopy (2003) 1.51
TRPgamma, a drosophila TRP-related subunit, forms a regulated cation channel with TRPL. Neuron (2000) 1.50
Genetic analysis of bacteriophage P4 using P4-plasmid ColE1 hybrids. Mol Gen Genet (1980) 1.48
Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience (1992) 1.48
Regulation of pancreatic beta-cell function by the forkhead protein FoxO1. Diabetes Obes Metab (2007) 1.47
Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm Res (2001) 1.46
Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science (1989) 1.46
Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk. Genet Mol Res (2011) 1.45
Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A (1989) 1.44
A siderophore from a marine bacterium with an exceptional ferric ion affinity constant. Nature (1993) 1.44
A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Acta Psychiatr Scand (2000) 1.43
A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest (1990) 1.42
Insulin regulation of gene expression through the forkhead transcription factor Foxo1 (Fkhr) requires kinases distinct from Akt. Biochemistry (2001) 1.40
GFPcre fusion vectors with enhanced expression. Anal Biochem (1999) 1.39
[A puzzling circulatory failure after total hip replacement]. Ann Fr Anesth Reanim (2003) 1.39
Neuroimaging for non-accidental head injury in childhood: a proposed protocol. Clin Radiol (2003) 1.39
Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem (1998) 1.38
SLO-2, a K+ channel with an unusual Cl- dependence. Nat Neurosci (2000) 1.37
Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest (1997) 1.37
Association between Ser311Cys polymorphism in the dopamine D2 receptor gene and schizophrenia risk: a meta-analysis in Asian populations. Genet Mol Res (2012) 1.37
Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest (1997) 1.36
Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol (1987) 1.34
Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology (1999) 1.34
Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest (1998) 1.34
Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest (1996) 1.33
Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor I. Proc Natl Acad Sci U S A (1987) 1.33
Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer (1981) 1.33
Predictors of glycemic control in children with type 1 diabetes: the importance of race. J Diabetes Complications (2000) 1.32
On the regiospecificity of vanadium bromoperoxidase. J Am Chem Soc (2001) 1.32
Segmental genomic replacement by Cre-mediated recombination: genotoxic stress activation of the p53 promoter in single-copy transformants. Nucleic Acids Res (1997) 1.32
The evolutionary origins of hormones, neurotransmitters, and other extracellular chemical messengers: implications for mammalian biology. N Engl J Med (1982) 1.31
Clinical review 125: The insulin receptor and its cellular targets. J Clin Endocrinol Metab (2001) 1.31
Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res (1999) 1.31